logo
logo
Sign in

The Global Mosquito Borne Disease Market Growth Accelerated By New Preventive Vaccines Developsment

avatar
Pooja Khodke
The Global Mosquito Borne Disease Market Growth Accelerated By New Preventive Vaccines Developsment

Mosquito borne diseases have been a major public health challenge for decades. Diseases like Malaria, Dengue, Chikungunya and Zika virus are transmitted to humans through the bites of infected female mosquitoes of different species, mainly Aedes and Anopheles. These diseases can cause severe illness and sometimes lead to death if untreated. The advent of new preventive vaccines to control the transmission of these diseases from mosquitoes to humans has fueled the growth of the mosquito borne disease market.


The global Mosquito Borne Disease Market is estimated to be valued at Us$ 3.11 Bn in 2023 and is expected to exhibit a CAGR Of 6.5% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:


The development of new preventive vaccines is one of the major trends being witnessed in the mosquito borne disease market. Regulatory approvals and commercialization of new vaccines such as dengue, chikungunya, zika and malaria vaccines in the recent past has accelerated the market growth. For instance, the WHO recommended use of Dengvaxia dengue vaccine for endemic populations 9 years of age and older in July 2019. Furthermore, European Commission has approved the four-strain dengue vaccine named QDENGA in November 2022, which is expected to contribute to the prevention of dengue disease. Novel technologies for vaccine development such as recombinant protein-based, DNA/RNA-based and viral vectored vaccines can further expand prevention capabilities and market opportunities going forward.


Segment Analysis


The global mosquito borne disease market is dominated by the dengue segment due to the high prevalence of dengue fever globally. According to the WHO, each year there are approximately 100-400 million new dengue infections worldwide. Dengue fever causes severe flu-like symptoms including fever, headache, rash and muscle and joint pains. If not treated timely, it can escalate to potentially lethal dengue hemorrhagic fever or dengue shock syndrome. Hence, the dengue segment commands over 50% share of the global mosquito borne disease market.

Key Takeaways


The Global Mosquito Borne Disease Market Demand is expected to witness high growth over the forecast period of 2023 to 2030. The market size is projected to grow from US$ 3.11 Bn in 2023 to over US$ 5 Bn by 2030, registering a CAGR of 6.5%.

Regional analysis


The Asia Pacific region currently dominates the global mosquito borne disease market due to the high disease burden of dengue, malaria and chikungunya in countries like India, Indonesia, Bangladesh and the Philippines. The APAC market accounted for over 40% share of the global market in 2023 and is expected to remain the fastest growing regional market till 2030.

Key players


Key players operating in the mosquito borne disease market are Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Johnson & Johnson, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc. Majority of the key players are focusing on developing newer therapeutics and vaccines for mosquito borne diseases like dengue, chikungunya and malaria.



Get more insights on this topic :

https://www.insightprobing.com/mosquito-borne-disease-control-market-driven-by-growing-disease-burden/

collect
0
avatar
Pooja Khodke
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more